Nexilis AG
Artificial muscle technology to treat sphincter dysfunction and incontinences
NEXILIS develops proprietary device products for fixation of implants in poor bone quality. Our Immediate Stabilisation System is the application of an implantable polymeric tube around the original implant. Through the use of ultrasonic energy, the polymeric tube is moulded into the pores of the host bone, forming a strong and uniform bond with the adjacent bone. The original device is then implanted in the denser bony environment created, leading to enhanced immediate stability.
Extracellular Matrix Coating allows coating of implants with a native extracellular matrix, leading to significantly improved long-term stabilisation of implants.
?Bisphosphonates block activity of osteoclasts, i.e. cells degrading bone. Our bisphosphonate coating allows coating of any implant surface, leading to significantly improved bone mineral density and enabling long-term stabilisation of implants.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
22.09.2025
Nexilis: The Venture Leader Medtech advancing bone reinforcement (venturelab.swiss)
16.06.2015
MyoPowers raises € 4.5M and moves to France (startupticker.ch)
17.04.2015
Nine hot start-ups, 400 visitors and Joe Jimenez (startupticker.ch)
22.04.2013
Myopowers an hochdotiertem Forschungsprojekt beteiligt (startupticker.ch)
13.07.2011
MyoPowers Closes Series B Investment of CHF 16 Million (startupticker.ch)
No milestones
No Jobs
No videos and documents
CTI Start-up Label
CTI Start-up enables entrepreneurs to realize their innovative idea professionally.
In a process of three phases, over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. At the end of the coaching process, the most promising start-up companies have the opportunity to receive the prestigious CTI Start-up ’Label’. In addition, the companies benefit from the wide CTI Start-up network of industry experts, experienced entrepreneurs, business angels, venture capitalists and has access to foundations such as de Vigier, STI, FIT, Gebert, Rüf, etc.
Until today, CTI Start-up reviewed more than 1 800 projects, and awarded over 200 start-up enterprises with the CTI Start-up Label. Over 85% of these companies are still in business and some have shown remarkable growth, which is a sign that CTI Start-up guides them to sustainable success.
CTI also promotes the culture of entrepreneurship at universities, teaching hospitals, technical institutes as well as universities of applied sciences. CTI Entrepreneurship offers workshops to students on how to bring innovation to the market.
Nexilis AG
Artificial muscle technology to treat sphincter dysfunction and incontinences
Website:
www.nexilis.ch
Headquarter:
Liestal
Foundation Date:
March 2005
Technology:
- Medtech
Sectors:
- Biomaterials
- Medical devices
- Medtech
- Orthopedics